Pharmacogenetic panel decreases medication-related adverse events in adults

Clinical Question

Can pharmacogenetic testing decrease adverse events for new drugs prescribed to adults?

Bottom line

In this large multinational study, 12-gene pharmacogenetic testing resulted in a modest reduction in overall adverse events but had an unclear effect on serious adverse events. 1b-

Study design: Randomized controlled trial (nonblinded)

Funding: Government

Setting: Other

Reviewer

Henry C. Barry, MD, MS
Professor
Michigan State University
East Lansing, MI


Discuss this POEM


Comments

ARUP KUMAR DHARA

Impact assessment

Excellent

Anonymous

Not ready for prime time

This may be better in time, but not yet